Left Atrial Appendage Closure with Transcatheter-Delivered Devices.

@article{Whisenant2014LeftAA,
  title={Left Atrial Appendage Closure with Transcatheter-Delivered Devices.},
  author={Brian K. Whisenant and Peter J Weiss},
  journal={Interventional cardiology clinics},
  year={2014},
  volume={3 2},
  pages={
          209-218
        }
}
Left atrial appendage (LAA) closure with transcatheter-delivered devices is an evolving story of compelling randomized data and the potential to dramatically reduce the incidence of stroke and improve the quality of life among patients with atrial fibrillation. Oral anticoagulation is the standard of care for stroke prevention in atrial fibrillation but falls short of providing an adequate solution to this common threat when considered from efficacy and safety perspectives. The robust series of… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-6 OF 6 CITATIONS

2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2015
VIEW 12 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview.

  • Journal of the American College of Cardiology
  • 2015
VIEW 13 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

executive summary: Boston Scientific WATCHMAN left atrial appendage closure therapy

FD FDA.
  • Prepared for the December 11, 2013 meeting of the Circulatory System Devices Panel. 2013. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/MedicalDevices/Medical DevicesAdvisoryCommittee/CirculatorySystemDevices Panel/UCM377356.pdf. Accessed January 21,
  • 2014
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

summary of the Circulatory System Devices panel meeting – December 11, 2013

FDA. Brie
  • 2013. Available at: http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Medical Devices/MedicalDevicesAdvisoryCommittee/Circulatory SystemDevicesPanel/UCM378634.pdf. Accessed January 21,
  • 2014
VIEW 1 EXCERPT

A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation.

  • Cardiovascular revascularization medicine : including molecular interventions
  • 2013
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…